Cumulus Neuroscience präsentiert auf der AAIC-Jahrestagung 2026 Daten, die zeigen, dass eine zweiminütige digitale Aufgabe die klinischen Referenzwerte für die Vorauswahl bei Alzheimer-Studien erreicht oder übertrifft

ConferencepositiveNeuLogiqPositive

AI Analysis

Summary

Cumulus Neuroscience presented data at AAIC 2026 demonstrating that its two-minute Symbol Swap digital task achieves clinical reference standards for Alzheimer's disease pre-screening across independent studies, showing meaningful discrimination between healthy controls, MCI, and dementia patients.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Two-minute digital Symbol Swap task demonstrated clinical meaningful discrimination between control, MCI, and Alzheimer's dementia patients and identified biomarker-defined populations

Importance:5/10

Sentiment:

0.70

Alzheimer's diseasedigital biomarkerscreening toolAAIC 2026mild cognitive impairmentblood biomarkers

Read the original article

Published by PR Newswire Biotech on July 16, 2026 7:22 AM

Read Original